Replies to post #884 on GTC Biotherapeutics (fka GTCB)

[read_this_n0w]

Siga Technologies (SIGA - commentary - Cramer's Take) soared more than 80% after its merger partner PharmAthene received a contract valued at up to $213 million from the Defense Department Army Space and Missile Command. The contract covers the advanced development of the company's chemical nerve agent prophylaxis, Protexia. Shares of Siga climbed 85 cents to $1.91.

-----------

normal correction?